10 individually packed test cassettes for detection of human IgG and IgM to European strains of Borrelia in human serum and plasma
Package contents:
10 Test cassettes
10 disposable pipettes
1 buffer bottle
1 package insert
Exclusively for professional users
Discover more than 2,000 medical and toxicological tests and POCT solutions
Please note: The prices shown are basic list prices. Your individual prices will be displayed after you have logged in to the shop. Your personal customer advisors can add them at any time.
The NADAL® Lyme Borreliosis IgG/IgM Test is a rapid qualitative screening test for the detection of human IgG and IgM to European strains of Borrelia in human serum and plasma. The test is intended for use as an aid in the diagnosis of Lyme disease, also known as Lyme borreliosis, and is designed for professional use only. However, in the case of a positive result, the NADAL® Lyme Borreliosis IgG/IgM Test does not enable the stage of the disease to be determined.
Lyme disease or Lyme borreliosis is caused by the spirochete Borrelia burgdorferi sensu lato, which is transmitted by ticks. Contagious ticks, infected by Borrelia burgdorferi sensu lato, are mainly found in North America (Ixodes scapularis or Ixodes pacificus) and in temperate areas of Western Europe (Ixodes ricinus). European tick species are vectors of European Borrelia strains, such as B. burgdorferi sensu stricto, B. afzelii, B. garinii as well as B. spielmanii and B bavariensis, which are also known to be pathogenic. B. valaisiana and B. lusitaniae are also considered to be potentially pathogenic strains. Due to the high similarity amongst Borrelia strains, IgG and IgM directed against different Borrelia species cross-react with the antigen cocktail of the NADAL® Lyme Borreliosis IgG/IgM Test - at least in the case of European strains. In 30% to 80% of cases, a skin rash (erythema chronicum migrans) is the first clinical sign of the infection, appearing after 3 to 10 days at the site of the tick bite. Between 1 and 3 months later, the first neurological signs, such as a headache or severe disorders like myelitis, appear - even in the absence of erythema chronicum migrans. Patients may also develop severe complications, such as intermittent attacks of articular arthritis, myocarditis or acrodermatitis much later, even several years after the primary infection.
More Information
More Information
SKU
870001N-10
Testformat
test cassette
Test evaluation
Provides a qualitative test result
Sample type
Serum, Plasma
Detected parameter
Lyme Borreliosis IgG/IgM
Package size
10 individually packed test cassettes
Detection time
Test result after 10 minutes
Storage temperature
The test should be stored at 4 - 30 °C
CE-Label
Yes
Pathogentype
Bacterial infection
Documents
No files available.
Attachments
No files available.
Copyright @2023 nal von minden GmbH. All rights reserved.
